REDUCTION OF HEALTH COSTS

MEDICAL MARKETING SUPERHEROES

BLOCKCHAIN TECHNOLOGY

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

The Virtual World of Digital Clinical Trials

Academic Ventures and Professional Service Companies

MICRONEEDLE ARRAY PATCHES

Systematic Framework for Implementation of RTD-based Control System into Continuous Pharmaceutical Manufacturing Pilot-plant

CUSTOMER CENTRICITY ON SOCIAL MEDIA

IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS

Get instant access to latest e-book

LATEST NEWSRead more...

22

May 2019

Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration

Gotham Therapeutics a biotechnology company developing a novel drug class targeting RNAmodifying proteins and ZoBio the leading contract research organization in integrated fragmentbased drug discovery today announced significant progress made as part of their collaboration to identify therapeutic l...

22

May 2019

Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline

Merck known as MSD outside the United States and Canada and Peloton Therapeutics Inc today announced that the companies have entered into a definitive agreement under which Merck through a subsidiary will acquire privately held Peloton a clinicalstage biopharmaceutical company

21

May 2019

Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology

Kazia Therapeutics Limited an Australian oncologyfocused biotechnology company is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation Alliance a USbased cancer research network sponsored by the National Cancer Institute

21

May 2019

Personalis Enters into a Research Agreement with FLX Bio to Provide Comprehensive Tumor Immunogenomic Profiling for Clinical Study

Personalis Inc a leader in advanced genomics for cancer today announced that it has entered into a research agreement with FLX Bio Inc a biopharmaceutical company developing orallyavailable small molecule drugs targeting the immune drivers of cancer and inflammatory diseases

17

May 2019

RegeneRx Partner Receives Patent for New Ophthalmic Formulation of Thymosin Beta 4

RegeneRx Biopharmaceuticals Inc a clinicalstage drug development company focused on tissue protection repair and regeneration reported today that its US joint venture partner and Pan Asian licensee GtreeBNT has been granted a new US patent for a method of preventing or treating dry eye syndrome

press releasesRead more...

22

May 2019

Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy

Avalon GloboCare Corp a leading global developer of cellbased technologies and therapeutics today announced it has entered into a sponsored research and licensing agreement with Massachusetts Institute of Technology MIT to generate novel therapeutic targets for cellular therapy using artificial inte...

22

May 2019

Santhera Starts Collaboration in Gene Therapy Research for Congenital Muscular Dystrophy with the Biozentrum, University of Basel, Co-Financed by Innosuisse

Santhera Pharmaceuticals announces its collaboration with the Biozentrum of the University of Basel to advance gene therapy research for the treatment of LAMAdeficient congenital muscular dystrophy LAMA MD or MDCA

21

May 2019

SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors

SpringWorks Therapeutics a clinicalstage biopharmaceutical company focused on developing lifechanging medicines for patients with severe rare diseases and cancer today announced that the first patient has been dosed in the Phase DeFi DesmoidFibromatosis trial evaluating nirogacestat an oral selecti...

21

May 2019

BioXcel Therapeutics Achieved Targeted Exposures of BXCL501 Designed For Non-Invasive Acute Treatment of Agitation in Neuropsychiatric Diseases

BioXcel Therapeutics Inc today announced positive top line data from its Phase pharmacokinetic PK bioavailability and safety study of BXCL a proprietary sublingual thinfilm formulation of dexmedetomidine Dex for the acute treatment of agitation across multiple neuropsychiatric indications

17

May 2019

Strong line-up: Chemspec Europe 2019 gathers impressive array of industry experts under one roof

Preparations for the International Exhibition for Fine and Speciality Chemicalsare well under way From June the thedition of Chemspec Europe provides a powerful and wellknown industry platform to explore bespoke solutions new approaches and innovative substances as well as to discuss the latest m...

EventsRead more...

20 - 23

May 2019

TIDES: Oligonucleotide and Peptide Therapeutics

KNect365
Manchester Grand Hyatt

21 - 23

May 2019

Neuroimmunology Drug Development Summary Summit

Hanson Wade
Hilton Paris La Defense

21 - 23

May 2019

Precision CRISPR Genome

Hanson Wade
Westin Boston Waterfront

23 - 23

May 2019

10th Annual Clinical Trials Summit 2019

Virtue Insight
Kohinoor Continental Hotel

AirBridgeCargo - Air frieght solutions for your Pharma

ACG’s Packdoctors - Get your common packaging problems treated

$Matcon Efficently handling tablets and powders in IBC\'s$

KNOWLEDGE BANK

Interviews

Merck

Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

Articles

Industry 4.0: a closed micronization system

FPS is an Italian company specialized in the production of containment and micronization systems for Pharmaceutical Biotech and Fine Chemical companies

Research Insights

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to in

Case Studies

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime

Techno Trends

UW–Madison School of Pharmacy Designs New Compounds to Fight Deadly Mosquito-Transmitted Viruses

UWMadison school of Pharmacy designed a breakthrough in creating new small molecules that penetrate into the brain where the virus resides and interfere with viral replication to stop Equine Encephalitis Viruses EEV

White Papers

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward

Advisory Board

Stella

Sanjoy Ray

Rustom

Phil

Neil J

Laurence

Kenneth I

Georg C

Frank A

Douglas

Christopher-

Alan S Louie

EDITORIAL SECTION

STRATEGY

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

Seventy years ago average life expectancy globally was today it is Seventy years ago million people worldwide were infected with smallpox today non...

RESEARCH DEVELOPMENT

Academic Ventures and Professional Service Companies

Over the past few decades life science and pharma have been characterised by a series of radical changes that have been at the origin of an impressive...

CLINICAL TRIALS

Speed, Quality and Cost

In recent years the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market being under increasin...

MANUFACTURING

CLINICAL MANUFACTURING ON TIME AND WITHIN BUDGET

The key to successfully developing and shepherding a drug to the approval stage and beyond lies in careful planning right from the start of developmen...

Information Technology

CUSTOMER CENTRICITY ON SOCIAL MEDIA

Imagine checking into a hotel late in the night but not being able to get the room you had so carefully chosen because the call centre didnt align wit...

EXPERT Talk

How SMEs Can Achieve Regulatory Compliance through a Risk-Based Approach

What is the current consensus on the ICH E R Addendum within SMEs The complexity and size of clinical trials has intensified over recent years alo...

REDUCTION OF HEALTH COSTS

MEDICAL MARKETING SUPERHEROES

BLOCKCHAIN TECHNOLOGY

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

The Virtual World of Digital Clinical Trials

Academic Ventures and Professional Service Companies

MICRONEEDLE ARRAY PATCHES

Systematic Framework for Implementation of RTD-based Control System into Continuous Pharmaceutical Manufacturing Pilot-plant

CUSTOMER CENTRICITY ON SOCIAL MEDIA

IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS

Get instant access to latest e-book

LATEST NEWSRead more...

22

Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration

22

Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline

21

Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology

21

Personalis Enters into a Research Agreement with FLX Bio to Provide Comprehensive Tumor Immunogenomic Profiling for Clinical Study

17

RegeneRx Partner Receives Patent for New Ophthalmic Formulation of Thymosin Beta 4

press releasesRead more...

22

Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy

22

Santhera Starts Collaboration in Gene Therapy Research for Congenital Muscular Dystrophy with the Biozentrum, University of Basel, Co-Financed by Innosuisse

21

SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors

21

BioXcel Therapeutics Achieved Targeted Exposures of BXCL501 Designed For Non-Invasive Acute Treatment of Agitation in Neuropsychiatric Diseases

17

Strong line-up: Chemspec Europe 2019 gathers impressive array of industry experts under one roof

EventsRead more...

20 - 23

TIDES: Oligonucleotide and Peptide Therapeutics

21 - 23

Neuroimmunology Drug Development Summary Summit

21 - 23

Precision CRISPR Genome

23 - 23

10th Annual Clinical Trials Summit 2019

Advertisements

TOP ARTICLES

1

Nanomedicines management for advance therapy of NeuroAIDS: State of art

2

Mock-up in The Design Stage - FPS’s particular attention

3

MicroRNA (miRNA) in Nanostructure Lipid Carriers based Tumor Gene Therapy

4

Identification of MicroRNAs and Their Targets in Cancer

5

Are you Ready for EU FMD?

KNOWLEDGE BANK

Merck

Industry 4.0: a closed micronization system

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

UW–Madison School of Pharmacy Designs New Compounds to Fight Deadly Mosquito-Transmitted Viruses

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Advisory Board

EDITORIAL SECTION

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

Academic Ventures and Professional Service Companies

Speed, Quality and Cost

CLINICAL MANUFACTURING ON TIME AND WITHIN BUDGET

CUSTOMER CENTRICITY ON SOCIAL MEDIA

How SMEs Can Achieve Regulatory Compliance through a Risk-Based Approach